Wegovy maker Novo Nordisk boosted by successful weight loss pill launch
Wegovy maker Novo Nordisk said surging demand for its first weight loss pill has put it on track…
FDA Crackdown and Oral Ozempic Launch Set Stage for Earnings
Novo Nordisk enters a pivotal week with an FDA shortage-list victory, oral Ozempic rollout, and partnerships to capture…
Canadian Generic Launch and Q1 Results Loom
Health Canada authorizes Dr. Reddy’s biosimilar semaglutide, threatening Novo Nordisk’s Ozempic revenue as share buyback reaches 3.44 billion…
Novo Nordisk’s AI Bet and High-Dose Launch Face a Revenue Reality Check
Novo Nordisk shares surge on OpenAI partnership and buybacks, but Wall Street is cautious due to sales mix,…
Launch of the Pētersala residential project (Riga, Latvia)
Petersala visualisation 1 Petersala visualisation 1 Get the latest news delivered to your inbox Sign up for The…
Novo Nordisk Responds to Rival Launch with Clinical Data and Subscription Model
Novo Nordisk releases head-to-head data favoring oral Wegovy over Foundayo and launches a direct-to-consumer subscription plan to retain…